Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review

• Type: Another Publication in an International Scientific Journal
• Date: 2020

Authors

Costa Moreira, P (Author) Other; Lopes, S (Author) FMUP; Santos, AL (Author) Other; Pedrosa, AF (Author) Other; Andrade, P (Author) Other; Portugal, R (Author) Other; Macedo G (Author) FMUP

Journal

Title: Journal of Crohn's and Colitis

Vol. 14

Pages: 274-276

ISSN: 1873-9946

Publisher: Oxford University Press

Indexing

ISI Web of Knowledge - 7 Citations

Scopus - 8 Citations

Other information

Authenticus ID: P-00R-QJ7

DOI: 10.1093/ecco-jcc/jjz128

Abstract (EN): Leukocytoclastic vasculitis is a single-organ, skin-isolated small vessel vasculitis. It can be a side effect of many common drugs, including biological agents. Unlike with other drugs, leukocytoclastic vasculitis induced by biological agents may have a prolonged latency period. We report the first case of ustekinumab-induced leukocytoclastic vasculitis in a patient with inflammatory bowel disease.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 3